PRECISION BIOSCIENCES INC·4

Mar 7, 5:16 PM ET

List Alan 4

4 · PRECISION BIOSCIENCES INC · Filed Mar 7, 2023

Insider Transaction Report

Form 4
Period: 2023-03-03
List Alan
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-03+29,45347,713 total
  • Sale

    Common Stock

    2023-03-06$1.07/sh9,473$10,13638,240 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-03-03+29,45358,890 total
    Common Stock (29,453 underlying)
Footnotes (4)
  • [F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  • [F4]On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION